This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents. Top assignee: Reven Pharmaceuticals, Inc.. Active years: 2017-2021.
Company Filing History:
Years Active: 2017-2021
Title: Zishan Haroon: Innovator in Magnetic Dipole Stabilized Solutions
Introduction
Zishan Haroon is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of medical treatments through his innovative approaches. With a total of 3 patents, Haroon is recognized for his work in developing solutions that address various health conditions.
Latest Patents
One of Haroon's latest patents is titled "Method of treating or ameliorating skin conditions with a magnetic dipole stabilized solution." This invention focuses on methods for treating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections, or metal poisoning. The method involves administering compositions that include a magnetic dipole stabilized solution (MDSS) to individuals in need. The MDSS solution may also contain additional components and can be provided in a kit for ease of use.
Another patent by Haroon shares a similar focus, emphasizing the versatility of the MDSS in enhancing performance and providing nutritional support. This highlights his commitment to advancing medical treatments through innovative solutions.
Career Highlights
Zishan Haroon is currently associated with Reven Pharmaceuticals, Inc., where he continues to develop groundbreaking medical solutions. His work has garnered attention for its potential to improve health outcomes for various conditions.
Collaborations
Haroon collaborates with talented individuals in his field, including Peter Lange and Brian D Denomme. These partnerships enhance the innovative capacity of his projects and contribute to the advancement of medical technology.
Conclusion
Zishan Haroon stands out as an inventor dedicated to improving health through innovative solutions. His work with magnetic dipole stabilized solutions showcases his commitment to addressing critical medical challenges.